GILD Exercise Disclosure
Berger Dietmar · SEC Form 4 · Filed Sep 11, 2026
Exercise
Reported value range
Not reported
Berger Dietmar Chief Medical Officer
GILD
Gilead Sciences Inc
GILD
Transaction date
Sep 10, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 1 day later
GILD daily price context
Close on/before transaction
$144.81
Sep 10, 2026
Close before public filing
$144.81
Sep 10, 2026
Return since public filing
-0.85%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 533 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001739515-26-000011
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$38.09K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Gilead Sciences, Inc. GILD | Disposition | Sep 10, 2026 | $38.09K |
| Gilead Sciences, Inc. GILD Current | Exercise | Sep 10, 2026 | Not reported |
| Gilead Sciences, Inc. GILD | Exercise | Sep 10, 2026 | Not reported |